Zinc Protoporphyrin Test

Zinc protoporphyrin (ZPP) is a molecule naturally produced during the body’s creation of heme, the iron-containing part of hemoglobin that carries oxygen in your blood. Under healthy conditions, an enzyme called ferrochelatase inserts iron into a structure called protoporphyrin IX to form heme. However, if iron levels are low or iron cannot be properly used, as happens in iron deficiency or lead poisoning, the body instead inserts zinc into the protoporphyrin. This leads to the formation of ZPP instead of heme.

Most ZPP production happens inside the bone marrow, where red blood cells are made. Because ZPP rises early when iron is lacking or iron use is disrupted, measuring ZPP levels in blood can serve as a sensitive early warning sign of iron deficiency, even before typical lab results like hemoglobin levels start to drop. The ZPP-to-heme ratio, which compares how much ZPP has formed relative to normal heme, is often used to detect problems in red blood cell production.

ZPP testing is also a valuable tool for screening lead poisoning. Lead disrupts the normal insertion of iron into protoporphyrin, pushing the body to make even more ZPP. That is why children and adults exposed to lead are often screened using ZPP levels. In some settings, such as pediatrics, pregnancy care, and blood donation programs, ZPP is used to quietly monitor iron health and identify people at risk before symptoms develop.

Aside from being a marker for iron and lead issues, ZPP may play roles in regulating how heme is broken down. It appears to competitively block heme oxygenase, the enzyme that normally degrades heme into bilirubin (a yellow pigment) and carbon monoxide (a signaling molecule). Researchers are exploring whether ZPP could be used therapeutically to limit bilirubin production in newborns at risk of jaundice (a condition where bilirubin builds up to unhealthy levels).

Finally, new research is investigating ZPP’s role in cancer therapy. Since cancer cells often have high levels of heme oxygenase to protect themselves from stress, blocking this enzyme with ZPP may make tumors more vulnerable to chemotherapy and radiation. Scientists are studying ways to deliver ZPP directly into tumors, such as packaging it in nanoparticles, to avoid harming healthy tissues.